Neopharm Group is engaged in research and development, manufacturing, marketing, sales and distribution of a broad range of products in the health care field in 60 countries globally. Founded in 1941, over 900 employees worldwide, offices in Israel, Europe, U.S. and the Middle East and annual revenues exceeding $US400 million. We operate in three main areas: pharmaceuticals, consumer products and medical device. Group companies, among others: "Neopharm Israel" provides innovative solutions for improving health in the fields of oncology, hematology, autoimmune and metabolic diseases, neurology, gastroenterology and dermatology. Also Imports drugs that are unregistered in Israel with a permit of the Ministry of Health. Provides medical care to patients in their own home as an alternative to hospitalization. "Neovi" Swiss-based global biopharmaceutical company developing and bringing to market novel antibody therapies in transplantation medicine, oncology and immune disorders. "Eldan" provides medical, analytical and scientific instruments and equipment as well as advanced materials and technologies in the areas of healthcare and life science. "Neopharm consumer products" offers wellness and healthcare products via our in-house development and via partnering with world's leading Consumer Healthcare companies. Operates in the areas of nutrition, wet-wipes, diapers, skin care and over the counter medicines. "Promedico" provides logistics and supply chain management services. "Neopharm Cure" specializes in the preparation and delivery of medicinal treatments, given by infusion, customized for patients in hospitals, in the community or at home. "DPL" specializes in the production, marketing and export of advanced absorbent products such as: disposable diapers, wipes and sanitary napkins. To work at Neopharm is to be part of a large group that operates with humanity, professionalism and innovation. For all Jobs: https://www.neopharmgroup.com/careers/new/public
| Website | https://neopharmgroup.co.il/ |
| Revenue | $122.6 million |
| Employees | 171 (117 on RocketReach) |
| Founded | 1941 |
| Address | 6 Hashiloach St, Petah Tiqwa, Central District 4917001, IL |
| Phone | +972 3-937-3737 |
| Fax | +972 3-926-8548 |
| Technologies |
JavaScript
,
HTML
,
PHP
+29 more
(view full list)
|
| Industry | Manufacturing, Pharmaceutical Manufacturing, Manufacturing General, Therapeutics, Marketing, Health Care, Pharmaceuticals, Nutritionals, Hospital Products, Medical Devices And Diagnostics, Supply Chain Management |
| Web Rank | 5 Million |
| Keywords | Neopharm, Tal Fuhrer, Neopharm Group, ניאופרם, Neopharm Israel |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Neopharm Group employee's phone or email?
The Neopharm Group annual revenue was $122.6 million in 2026.
Efi Shnaidman is the CEO, Neopharm Israel of Neopharm Group.
117 people are employed at Neopharm Group.
Neopharm Group is based in Petah Tiqwa, Central District.
The NAICS codes for Neopharm Group are [5417, 541, 54].
The SIC codes for Neopharm Group are [87, 873].